News/ News/ Sales and Marketing Bayer sells testosterone drug rights to Grünenthal for €500m Phil Taylor Bayer, Grunenthal, Nebido, Sales and Marketing, testosterone 0 Comment Bayer’s venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as Share X Bayer sells testosterone drug rights to Grünenthal for €500m https://pharmaphorum.com/news/bayer-sells-testosterone-drug-rights-to-grunenthal-for-e500m/
Bayer, Grunenthal, Nebido, Sales and Marketing, testosterone
0 Comment
